As the nation continues to cope with this devastating pandemic, it’s time to look back on the resources we could count on during this challenging period. We want to hear from patients: Have you continued to receive your prescription generic and biosimilar medicines? What changed—or didn’t—for you and your family?
Patient stories like yours are essential as federal and state policies arise that might affect your access. Please use this tool to start the conversation. We won’t use your story without checking with you.
Some prompts and helpful hints to get you started:
AAM respects your privacy and won’t share any of your personal information without your consent.